StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5
Publishing Date
2023 - 12 - 11
8
2023 - 11 - 27
8
2023 - 10 - 25
11
2023 - 10 - 12
9
2023 - 07 - 17
10
2023 - 07 - 11
8
2023 - 06 - 28
9
2023 - 05 - 09
11
2023 - 03 - 28
10
2023 - 03 - 23
8
2023 - 02 - 28
8
2023 - 02 - 22
9
2023 - 01 - 05
7
2022 - 12 - 15
7
2022 - 10 - 24
7
2022 - 09 - 14
7
2022 - 06 - 21
8
2022 - 05 - 24
12
2022 - 05 - 18
8
2022 - 05 - 11
7
2022 - 05 - 09
9
2022 - 03 - 16
10
2022 - 03 - 15
7
2022 - 03 - 03
7
2022 - 02 - 28
8
2022 - 02 - 24
10
2022 - 02 - 14
7
2022 - 01 - 05
10
2021 - 12 - 07
8
2021 - 11 - 30
8
2021 - 11 - 18
7
2021 - 11 - 16
7
2021 - 11 - 11
10
2021 - 11 - 03
7
2021 - 10 - 25
7
2021 - 10 - 19
9
2021 - 10 - 12
8
2021 - 09 - 22
7
2021 - 08 - 24
7
2021 - 08 - 23
7
2021 - 08 - 17
7
2021 - 07 - 29
9
2021 - 07 - 27
8
2021 - 07 - 22
8
2021 - 07 - 07
7
2021 - 06 - 24
9
2021 - 06 - 22
8
2021 - 06 - 17
7
2021 - 06 - 16
10
2021 - 06 - 10
7
2021 - 06 - 08
7
2021 - 05 - 24
10
2021 - 05 - 17
8
2021 - 05 - 03
8
2021 - 04 - 13
9
2021 - 04 - 08
7
2021 - 02 - 26
8
2021 - 02 - 22
8
2021 - 02 - 08
9
2021 - 01 - 11
7
Sector
Health technology
4
Tags
Acquisition
4
Air
4
Alliances
4
America
4
Announcement
4
Asco
4
Automotive
3
Awards
5
Biocapital
3
Biomidwest
5
Biotech-bay
8
Biotech-beach
7
Biotechnology
5
Canada
3
Cancer
4
Care
4
China
3
Cloud
3
Collaboration
3
Conference
35
Construction
4
Contract
4
Corporation
9
Day
5
Designation
3
Disease
5
Distribution
8
Drug
3
Earnings
12
Energy
13
Enroll
3
Europe
3
Events
11
Fda
5
Genetown
7
Group
10
Growth
13
Health
6
Innovation
3
International
3
Management
4
Market
30
N/a
372
One
4
Pharm-country
5
Phase 1
5
Positive
4
Presentation
7
Program
5
Report
48
Repurchase
4
Research
13
Results
105
Service
6
Services
4
System
6
Technology
7
Therapeutics
15
Treatment
7
Trial
8
Entities
Abbvie inc.
3
Glaxosmithkline plc
1
Novartis ag
1
Sanofi
1
Teva pharmaceutical industries ltd
1
Vaxxinity, inc.
1
Symbols
ABBV
3
GLAXF
1
GSK
1
NVS
1
NVSEF
1
SNY
1
SNYNF
1
TEVJF
1
VAXX
1
Exchanges
Nasdaq
3
Nyse
3
Crawled Date
2022 - 04 - 28
5
Crawled Time
10:00
1
16:00
1
19:00
1
21:00
1
22:00
1
Source
www.biospace.com
4
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2022 - 04 - 28
tags :
Disease
save search
AbbVie Unites with Plexium to Leverage Protein Degraders Against Neurological Diseases
Published:
2022-04-28
(Crawled : 22:00)
- biospace.com/
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
8.56%
|
O:
0.6%
H:
0.0%
C:
0.0%
neurological
disease
AbbVie Unites with Plexium to Leverage Protein Degradation Against Neurological Diseases
Published:
2022-04-28
(Crawled : 21:00)
- biospace.com/
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
8.56%
|
O:
0.6%
H:
0.0%
C:
0.0%
neurological
disease
Vaxxinity Completes Enrollment in Part B of UB-312 Phase 1 Clinical Trial for Parkinson’s Disease
Published:
2022-04-28
(Crawled : 19:00)
- biospace.com/
VAXX
|
$0.13
-35.0%
-53.85%
4.6M
|
|
-94.46%
|
O:
-1.94%
H:
8.76%
C:
6.5%
ub-312
disease
trial
enroll
phase 1
USD 438.03 Mn growth expected in Krabbe Disease Treatment Market | North America to emerge as key market | Technavio
Published:
2022-04-28
(Crawled : 16:00)
- prnewswire.com
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
40.13%
|
O:
1.95%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-30.89%
|
O:
-3.19%
H:
1.56%
C:
1.56%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
27.08%
|
O:
-0.44%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
10.57%
|
O:
-0.38%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-9.24%
|
O:
-0.59%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
8.56%
|
O:
0.6%
H:
0.0%
C:
0.0%
america
treatment
disease
growth
market
OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases
Published:
2022-04-28
(Crawled : 10:00)
- biospace.com/
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-12.48%
|
O:
-2.96%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-13.08%
|
O:
-2.36%
H:
0.0%
C:
0.0%
rare
drug
immunology
therapeutics
disease
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.